Although on basis of these and similar findings in other tumor entities [36], DDR1 emerges as a promising novel target to interfere with tumorigenicity, an explicit involvement of DDR1 in the process of CAM-DR is experimentally still lacking. This evidence concerns the gene DDR1 and neoplasm.